Patents by Inventor Daniel Eberli

Daniel Eberli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INJECTION DEVICE
    Publication number: 20260077137
    Abstract: Provided is an injection device for injection of a substance with an syringe into an organism, comprising a holding unit, which is adapted to hold the syringe, an actuating unit, which is adapted for dosed injection of the injection substance and which is removably coupled to the holding unit and couplable with the syringe when the holding unit holds the syringe, a needle guide which is adapted to be removably couplable with an injection needle and for changing the injection position of the injection needle; and a connection structure which connects the holding unit and the needle guide.
    Type: Application
    Filed: September 1, 2023
    Publication date: March 19, 2026
    Inventors: Florian SCHMID, Beatrix RAUCH SCHMID, Rita PETTINELLO, Daniel EBERLI, Michael KUMMER, Ulrich Samuel Nino LEMANN, Philipp STÜCKLIN
  • METHOD FOR XENO-FREE GENERATION OF A POPULATION OF HMPC
    Publication number: 20250319138
    Abstract: The present invention concerns a method of generating a population of skeletal muscle derived human muscle precursor cells. For this purpose, a specialized FBS-free cell growth medium is used. The invention further concerns a composition comprising such a population of hMPCs for use as a medicament, especially in the treatment of skeletal muscle dysfunction.
    Type: Application
    Filed: June 26, 2025
    Publication date: October 16, 2025
    Applicant: UNIVERSITAT ZÜRICH
    Inventors: Daniel EBERLI, Deana MOHR, Souzan SALEMI, Fahd AZZABI ZOURAQ
  • Method for xeno-free generation of a population of hMPC
    Patent number: 12370221
    Abstract: The present invention concerns a method of generating a population of skeletal muscle derived human muscle precursor cells. For this purpose, a specialized FBS-free cell growth medium is used. The invention further concerns a composition comprising such a population of hMPCs for use as a medicament, especially in the treatment of skeletal muscle dysfunction.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: July 29, 2025
    Assignee: UNIVERSITÄT ZÜRICH
    Inventors: Daniel Eberli, Deana Mohr, Souzan Salemi, Fahd Azzabi Zouraq
  • PROSTATE CANCER CLINICAL STATUS MARKERS
    Publication number: 20250067741
    Abstract: The present invention relates to the field of assessment of the health status, particular with regard to prostate cancer risk, by measurement of certain proteins in human samples, in particular in human urine.
    Type: Application
    Filed: December 16, 2022
    Publication date: February 27, 2025
    Applicant: UNIVERSITÄT ZÜRICH
    Inventors: Irina BANZOLA, Blaz PAVLOVIC, Nagjie Laila ALIJAJ, Daniel EBERLI
  • METHOD FOR XENO-FREE GENERATION OF A POPULATION OF HMPC
    Publication number: 20210244770
    Abstract: The present invention concerns a method of generating a population of skeletal muscle derived human muscle precursor cells. For this purpose, a specialized FBS-free cell growth medium is used. The invention further concerns a composition comprising such a population of hMPCs for use as a medicament, especially in the treatment of skeletal muscle dysfunction.
    Type: Application
    Filed: May 6, 2019
    Publication date: August 12, 2021
    Applicant: UNIVERSITÄT ZÜRICH
    Inventors: Daniel EBERLI, Deana MOHR, Souzan SALEMI, Fahd AZZABI ZOURAQ
  • Prevention of bacterial adherence and growth in an urological implant
    Patent number: 8951241
    Abstract: A medical device is disclosed, which comprises a functional unit (C) for permanent or temporary placement in the urogenital tract of a human or animal body. The functional unit has at least one electrically conducting portion. A power source (G) supplies a current to the electrically conducting portion after placement of the functional unit in the urogenital tract. In this manner, the growth of bacteria on the functional unit can be reduced.
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: February 10, 2015
    Assignees: Universitat Zurich, ETH Zurich
    Inventors: Daniel Eberli, Lukas Hefermehl, Michael Gabi, Alexandre Lar-Magnac, Janos Voros
  • Prevention of Bacterial Adherence and Growth in an Urological Implant
    Publication number: 20130123756
    Abstract: A medical device is disclosed, which comprises a functional unit (C) for permanent or temporary placement in the urogenital tract of a human or animal body. The functional unit has at least one electrically conducting portion. A power source (G) supplies a current to the electrically conducting portion after placement of the functional unit in the urogenital tract. In this manner, the growth of bacteria on the functional unit can be reduced.
    Type: Application
    Filed: July 6, 2011
    Publication date: May 16, 2013
    Applicants: ETH ZURICH, UNIVERSITAT ZURICH
    Inventors: Daniel Eberli, Lukas Hefermehl, Michael Gabi, Alexandre Lar-Magnac, Janos Voros